Evidence
Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18.
ABSTRACT
Dementias encompass a range of debilitating neurologic conditions. Here, we summarize the neuropathology of common forms of dementia, focusing on Alzheimer disease (AD) and related dementias. AD is part of a spectrum of neurodegenerative diseases that consists of various protein inclusions (ie, proteinopathies) but other brain abnormalities are also related to dementia. Beta-amyloid and tau aggregates are hallmarks of AD. Other tissue substrates include Lewy bodies, TDP-43 inclusions, vascular brain lesions, and mixed pathologies. This review highlights the complexity of neurodegenerative and other disease substrates and summarizes topography of these lesions and concepts of mixed brain pathologies, resistance, and resilience.
PMID:36404035 | DOI:10.1016/j.cger.2022.07.005
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Neuropathology of the Common Forms of Dementia
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases
- G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline
- Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier
- Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database
- Differences in trajectories of quality of life according to type of dementia: 6-year longitudinal findings from the IDEAL programme
- The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
- Current insights and assumptions on α-synuclein in Lewy body disease
- Neuroimmune Dysfunction in Alzheimer's Disease and Other Forms of Dementia
- Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias
- Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort
- Cleaved TMEM106B forms amyloid aggregates in central and peripheral nervous systems
- Phytoactive drugs used in the treatment of Alzheimer's disease and dementia
- The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
- The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
- Peripheral vascular dysfunction and the aging brain
- Advanced qEEG analyses discriminate between dementia subtypes
- Advanced qEEG analyses discriminate between dementia subtypes
- Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain
- Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells
- Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
- Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion
- Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases
- Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
- TDP43 Interacts with MLH1 and MSH6 Proteins in A DNA Damage-Inducible Manner
- Alcohol Use Disorder and Dementia: A Review
- Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review
- MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross-seeding ability
- Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort
- Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
- Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
- Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies
- Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease
- Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis
- Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging
- Young-Onset Alzheimer Dementia Due to a Novel Pathogenic Presenilin 1 Variant Initially Misdiagnosed as Autoimmune Encephalitis
- Young-Onset Alzheimer Dementia Due to a Novel Pathogenic Presenilin 1 Variant Initially Misdiagnosed as Autoimmune Encephalitis
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
- Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia
- Update on Therapies in Older Adults
- Update on Therapies in Older Adults
- Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases
- A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related Disorders
- A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related Disorders
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
- Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
- Role of Cardiac Biomarkers in Stroke and Cognitive Impairment
- Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease
- In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
- The Evaluation of Clinical Applications for the Detection of the Alzheimer's Disease Biomarker GFAP
- Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases
- Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy
- Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
- Drug repurposing for neurodegenerative diseases
- Coffee and tea are unlikely to be risk factors or preventers of Alzheimer's disease or vascular dementia
- Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation
- Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease
- Brain perfusion SPECT in dementia: what radiologists should know
Evidence Blueprint
Neuropathology of the Common Forms of Dementia
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Neuropathology of the Common Forms of Dementia
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- When prion disease Isn't suspected: prion disease as the cause of terminal decline in chronic mixed dementia
- Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Elucidating distinct molecular signatures of Lewy body dementias
- Ageing-Related Neurodegeneration and Cognitive Decline
- Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology
- G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Relative contributions of mixed pathologies to cognitive and functional symptoms in brain donors exposed to repetitive head impacts
- Polypathologic associations with grey matter atrophy in neurodegenerative disease
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders
- Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia: Dementia Series
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline
- Dem-Aging: autophagy-related pathologies and the "two faces of dementia"
- Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier
- Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database
- Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
- Oligodendrocytes play a critical role in white matter damage of vascular dementia
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Differences in trajectories of quality of life according to type of dementia: 6-year longitudinal findings from the IDEAL programme
- Lewy Body Dementias: Controversies and Drug Development
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
- The neuropathology of intimate partner violence
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- Current insights and assumptions on α-synuclein in Lewy body disease
- Neuroimmune Dysfunction in Alzheimer's Disease and Other Forms of Dementia
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation
- Neurodegeneration of White and Gray Matter in the Hippocampus with FXTAS
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G
- Innate immune activation in neurodegenerative diseases
- Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias
- Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala